Index RUT
P/E 36.28
EPS (ttm) 1.19
Insider Own 50.17%
Shs Outstand 20.37M
Perf Week 2.82%
Market Cap 1.74B
Forward P/E 14.37
EPS next Y 3.00
Insider Trans -0.50%
Shs Float 20.20M
Perf Month 15.98%
Enterprise Value 2.43B
PEG 2.21
EPS next Q 0.69
Inst Own 51.24%
Short Float 4.78%
Perf Quarter 53.17%
Income 48.26M
P/S 1.35
EPS this Y 29.31%
Inst Trans 1.38%
Short Ratio 3.08
Perf Half Y 93.44%
Sales 1.30B
P/B 6.11
EPS next Y 10.82%
ROA 4.12%
Short Interest 0.97M
Perf YTD 104.95%
Book/sh 7.05
P/C 22.64
EPS next 5Y 16.45%
ROE 17.80%
52W High 44.35 -2.95%
Perf Year 92.40%
Cash/sh 1.90
P/FCF 41.71
EPS past 3/5Y -0.76% 7.45%
ROIC 4.72%
52W Low 16.16 166.34%
Perf 3Y 189.25%
Dividend Est. 0.84 (1.95%)
EV/EBITDA 14.55
Sales past 3/5Y 11.22% 10.12%
Gross Margin 30.16%
Volatility 6.83% 4.74%
Perf 5Y 161.80%
Dividend TTM 0.48 (1.12%)
EV/Sales 1.87
EPS Y/Y TTM 1898.99%
Oper. Margin 9.36%
ATR (14) 1.93
Perf 10Y 30.86%
Dividend Ex-Date Nov 26, 2025
Quick Ratio 1.25
Sales Y/Y TTM 27.37%
Profit Margin 3.72%
RSI (14) 61.37
Recom 2.75
Dividend Gr. 3/5Y 0.00% 0.00%
Current Ratio 2.76
EPS Q/Q 2187.57%
SMA20 6.03%
Beta 0.77
Target Price 39.75
Payout 40.46%
Debt/Eq 2.67
Sales Q/Q 38.63%
SMA50 8.67%
Rel Volume 1.31
Prev Close 41.15
Employees 2475
LT Debt/Eq 2.58
Earnings Nov 05 AMC
SMA200 53.28%
Avg Volume 313.57K
Price 43.04
IPO Apr 11, 2014
Option/Short Yes / Yes
EPS/Sales Surpr. 17.27% 4.87%
Trades
Volume 409,913
Change 4.59%
Date
Action
Analyst
Rating Change
Price Target Change
Jul-07-25 Upgrade
JP Morgan
Neutral → Overweight
$35
Jun-16-25 Upgrade
BNP Paribas Exane
Underperform → Neutral
$24
Sep-10-24 Initiated
JP Morgan
Neutral
$22
Dec-07-23 Initiated
Exane BNP Paribas
Underperform
$9
Dec-21-22 Initiated
ROTH Capital
Buy
$18
Jul-25-22 Downgrade
Barclays
Equal Weight → Underweight
$22
Jan-10-22 Upgrade
Barclays
Underweight → Equal Weight
$23
Nov-18-21 Initiated
Morgan Stanley
Equal-Weight
$23
Aug-05-21 Resumed
Credit Suisse
Neutral
$25
Jul-07-21 Downgrade
Barclays
Equal Weight → Underweight
$23
Aug-06-20 Downgrade
Morgan Stanley
Equal-Weight → Underweight
$20
Feb-06-20 Downgrade
Gabelli & Co
Buy → Hold
$30
Jan-28-20 Upgrade
Barclays
Underweight → Equal Weight
Sep-05-19 Upgrade
Morgan Stanley
Underweight → Equal-Weight
$21 → $30
Aug-29-19 Reiterated
BofA/Merrill
Underperform
$29 → $18
Jun-11-19 Initiated
Barclays
Underweight
$25
May-23-19 Initiated
Guggenheim
Neutral
May-09-19 Upgrade
Gabelli & Co
Hold → Buy
$42
Aug-23-17 Resumed
BofA/Merrill
Underperform
$33
Jun-02-17 Downgrade
Credit Suisse
Outperform → Neutral
Show Previous Ratings
Today 04:13PM
Nov-05-25 08:30PM
07:25PM
06:19PM
(Associated Press Finance)
04:22PM
04:10PM
Loading…
Nov-04-25 04:10PM
07:55AM
Nov-03-25 12:08PM
Oct-31-25 04:05PM
(Investor's Business Daily)
10:17AM
04:51AM
Oct-30-25 01:00PM
12:24PM
10:00AM
Oct-29-25 04:00PM
10:00AM
Loading…
10:00AM
09:08AM
Oct-28-25 12:45PM
10:01AM
09:40AM
09:15AM
Oct-27-25 11:40AM
Oct-24-25 01:53PM
09:45AM
Oct-22-25 10:56AM
09:23AM
09:16AM
09:15AM
Oct-21-25 09:36AM
09:29AM
12:28PM
Loading…
Oct-20-25 12:28PM
(Investor's Business Daily)
Oct-17-25 09:40AM
Oct-15-25 10:12AM
Oct-10-25 11:40AM
08:39AM
08:35AM
Oct-09-25 04:30PM
Oct-08-25 09:45AM
08:18AM
Oct-07-25 08:39AM
08:23AM
05:35AM
03:34AM
Oct-06-25 08:04AM
08:04AM
Oct-03-25 08:44AM
08:21AM
08:21AM
Oct-01-25 01:42PM
09:40AM
Sep-30-25 06:27AM
Sep-29-25 08:22AM
Sep-26-25 11:30AM
09:40AM
08:41AM
Sep-25-25 09:31AM
08:24AM
Sep-24-25 11:40AM
08:56AM
08:55AM
Sep-23-25 08:22AM
08:19AM
Sep-22-25 09:45AM
09:28AM
Sep-19-25 12:45PM
12:00PM
08:14AM
08:09AM
Sep-18-25 03:00PM
09:01AM
08:43AM
Sep-17-25 09:50AM
08:52AM
Sep-16-25 10:41AM
10:38AM
08:20AM
Sep-15-25 09:40AM
09:01AM
Sep-12-25 08:51AM
08:48AM
08:44AM
Sep-11-25 08:25AM
Sep-10-25 10:04AM
09:45AM
09:40AM
09:30AM
Sep-09-25 08:04AM
Sep-08-25 08:14AM
Sep-05-25 10:56AM
10:17AM
08:50AM
Sep-04-25 12:14PM
10:51AM
08:50AM
Sep-03-25 12:45PM
09:18AM
08:51AM
Sep-02-25 04:26PM
04:00PM
Sep-01-25 10:21AM
Phibro Animal Health Corp. engages in the development, manufacture, and marketing of animal health and mineral nutrition products. It operates through the following segments: Animal Health, Mineral Nutrition, and Performance Products. The Animal Health segment focuses on the development and marketing of medicated feed additives, nutritional specialty products, and vaccines. The Mineral Nutrition segment includes formulations and concentrations of trace minerals such as zinc, manganese, copper, iron, and compounds. The Performance Products segment is involved in the manufacture and marketing of specialty ingredients for use in the personal care, automotive, industrial chemical, and chemical catalyst industries. The company was founded on May 11, 1946 and is headquartered in Teaneck, NJ.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
BENDHEIM JACK President and CEO Nov 04 '25 Sale 43.10 3,520 151,703 65,920 Nov 06 05:46 PM BENDHEIM JACK President and CEO Nov 05 '25 Sale 41.21 3,520 145,075 62,400 Nov 06 05:46 PM BENDHEIM JACK President and CEO Oct 29 '25 Sale 41.66 3,520 146,627 47,960 Oct 30 06:09 PM BENDHEIM JACK President and CEO Oct 28 '25 Sale 41.56 3,520 146,277 51,480 Oct 30 06:09 PM BENDHEIM JACK President and CEO Oct 30 '25 Sale 41.07 3,520 144,582 44,440 Oct 30 06:09 PM BENDHEIM JACK President and CEO Oct 22 '25 Sale 40.27 11,859 477,552 62,040 Oct 24 07:06 PM BENDHEIM JACK President and CEO Oct 24 '25 Sale 41.75 3,520 146,956 55,000 Oct 24 07:06 PM BENDHEIM JACK President and CEO Oct 23 '25 Sale 40.18 3,520 141,432 58,520 Oct 24 07:06 PM BENDHEIM JACK President and CEO Oct 20 '25 Sale 40.38 16,075 649,176 23,899 Oct 21 05:30 PM BENDHEIM JACK President and CEO Oct 17 '25 Sale 40.03 700 28,022 39,974 Oct 21 05:30 PM BENDHEIM JACK President and CEO Sep 30 '25 Sale 40.38 20,664 834,412 40,674 Oct 01 04:10 PM BENDHEIM JACK President and CEO Sep 18 '25 Sale 40.26 7,022 282,732 31,338 Sep 22 06:32 PM BENDHEIM JACK President and CEO Sep 09 '25 Sale 40.33 14,080 567,841 45,400 Sep 11 08:56 PM BENDHEIM JACK President and CEO Sep 10 '25 Sale 41.29 3,520 145,336 41,880 Sep 11 08:56 PM BENDHEIM JACK President and CEO Sep 11 '25 Sale 40.95 3,520 144,137 38,360 Sep 11 08:56 PM BFI Co. LLC 10% Owner Sep 04 '25 Proposed Sale 39.07 281,600 11,002,112 Sep 04 05:04 PM BFI Co., LLC 10% Owner Aug 19 '25 Proposed Sale 31.25 264,000 8,250,000 Aug 19 04:40 PM BFI Co., LLC 10% Owner May 19 '25 Proposed Sale 24.00 241,129 5,787,096 May 19 05:25 PM CORCORAN E THOMAS Director Feb 24 '25 Buy 22.10 5,000 110,500 30,000 Feb 26 04:15 PM BFI Co., LLC 10% Owner Feb 18 '25 Proposed Sale 25.77 247,769 6,385,007 Feb 18 05:35 PM